Original Article: Drug Allergy, Insect Sting Allergy, and Anaphylaxis
33 Articles |
-
Diagnostic value of a medical algorithm for investigation of perioperative hypersensitivity reactions
Sverrild, A., Carruthers, J., Murthee, K.G., et al. Allergy. First published: 22 September 2022
-
Resensitisation in suspected penicillin allergy
Doña, I., Guidolin, L., Bogas, G., et al. Allergy. First published: 06 September 2022
-
Personalized diagnostic approach and indirect quantification of extravasation in human anaphylaxis
Nuñez-Borque, E., Betancor, D., Carlos, P.-V., et al. Allergy. First published: 16 July 2022
-
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
-
Synthetic antigenic determinants of clavulanic acid induce dendritic cell maturation and specific T cell proliferation in patients with immediate hypersensitivity reactions
Fernandez-Santamaria, R, Bogas, G, Montañez, MI, et al. Allergy. First published: 24 May 2022
-
Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children
Upton, J.E.M., Hoang, J.A., Leon-Ponte, M.,et al. Allergy. First published: 09 April 2022
-
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis
Brockow, K, Mathes, S, Fischer, J, et al. et al. Allergy. First published: 22 November 2021
-
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021
-
Next-generation sequencing and genotype association studies reveal the association of HLA-DRB3*02:02 with delayed hypersensitivity to penicillins
Romano, A., Oussalah, A., Chery, C., et al. Allergy. First published: 23 October 2021
-
Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients
Mitamura, Y., Schulz, D., Oro, S., et al. Allergy. First published:22 June 2021
-
IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1
Grilo, J.R., Kitzmüller, C., Aglas, L., et al. Allergy. First published: 16 March 2021
-
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
-
Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams
Prieto, A., Muñoz, C., Bogas, G., et al. Allergy.2021; 76: 2544-2554
-
Childhood vaccination and allergy: A systematic review and meta-analysis
Navaratna, S., Estcourt, M.J., Burgess, J., et al. Allergy.2021; 76: 2135-2152
-
Dendritic cells inclusion and cell-subset assessment improve flow-cytometry-based proliferation test in non-immediate drug hypersensitivity reactions
Fernandez-Santamaria, R., Bogas, G., Palomares, F., et al. Allergy.2021; 76: 2123-2134
-
Drug-specific T-cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat
Thomson, PJ, Kafu, L, Meng, X, et al. Allergy. 2021; 76: 1825– 1835
-
Digital technology for anaphylaxis management impact on patient behaviour: A randomized clinical trial
Sala-Cunill, A, Luengo, O, Curran, A, et al. Allergy. 2021; 76: 1507– 1516
-
Diagnosing, managing and preventing anaphylaxis: Systematic review
de Silva, D, Singh, C, Muraro, A, et al. Allergy. 2021; 76: 1493– 1506
-
Diagnostic workup including CD203c-based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross-reactivity in between
Beyaz, Ş, Akdeniz, N, Yılmaz, A, et al. Allergy. 2021; 76: 842– 852
-
IgE-mediated chlorhexidine allergy—Cross-reactivity with other biguanide disinfectants
Mueller-Wirth, N, Buenter, A, Jörg, L, et al. Allergy. 2020; 75: 3237– 3247
-
Fatal anaphylaxis in Italy: Analysis of cause-of-death national data, 2004-2016
Bilò, MB, Corsi, A, Martini, M, Penza, E, Grippo, F, Bignardi, D. llergy. 2020; 75: 2644– 2652
-
Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort
Tyrak, KE, Pajdzik, K, Konduracka, E, et al. Allergy. 2020; 75: 1649– 1658
-
Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugs
Nohra, D, Molinari, N, Demoly, P, Chiriac, A-M. Allergy. 2020; 75: 1423– 1434
-
The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome
Jörg, L, Yerly, D, Helbling, A, Pichler, W. Allergy. 2020; 75: 1178– 1187
-
Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation
Thomson, PJ, Illing, PT, Farrell, J, et al. Allergy. 2020; 75: 636– 647
-
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection
Jarkvist, J, Salehi, C, Akin, C, Gülen, T. Allergy. 2020; 75: 169– 177
-
Large local reactions to Hymenoptera stings: Outcome of re-stings in real life
ilò, MB, Martini, M, Pravettoni, V, et al. Allergy. 2019; 74: 1969– 1976
-
Expression of the Tim3-galectin 9 axis is altered in drug-induced maculopapular exanthema
Fernandez-Santamaría, R, Palomares, F, Salas, M, et al. Allergy. 2019; 74: 1769– 1779
-
Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01
Zhao, Q, Alhilali, K, Alzahrani, A, et al. Allergy. 2019; 74: 1533– 1548
-
Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: An observational study
Vitte, J, Amadei, L, Gouitaa, M, et al. Allergy. 2019; 74: 1157– 1165
-
The orphan nuclear receptor NR4A1 promotes FcεRI-stimulated mast cell activation and anaphylaxis by counteracting the inhibitory LKB1/AMPK axis
Jin, F, Li, X, Deng, Y, et al. Allergy. 2019; 74: 1145– 1156
-
Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients
Boehm, T, Reiter, B, Ristl, R, et al. Allergy. 2019; 74: 583– 593
-
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Fettelschoss-Gabriel, A, Fettelschoss, V, Olomski, F, et al. Allergy. 2019; 74: 572– 582